Related Experiment Video
Updated: Jul 14, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Infections caused by Kluyvera species in humans
J C Sarria1, A M Vidal, R C Kimbrough
1Division of Infectious Diseases, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. medjcs@ttuhsc.edu
Abstract:
Kluyvera is a relatively newly described genus in the family Enterobacteriaceae that infrequently causes infections in humans. The organism has been isolated from various clinical specimens, but its significance has not been clearly established. In fact, it has been regarded alternatively as saprophytic, opportunistic, or pathogenic. Since the redefinition of this genus in 1981, case reports of diverse clinical infections occurring under various host conditions have been published. Here we present a critical review of all Kluyvera infections reported in the literature, along with our experience involving 5 additional cases. Most patients received prompt antimicrobial treatment on the basis of susceptibility testing, and overall the clinical outcomes were good. Antimicrobial agents active against most Kluyvera strains include third-generation cephalosporins, fluoroquinolones, and aminoglycosides. In contrast, the resistance to ampicillin, extended-spectrum penicillins, and first- and second-generation cephalosporins is significant. Kluyvera is a potentially virulent pathogen that deserves aggressive treatment designed with an awareness of the organism's antimicrobial resistance patterns.
Insights
Kluyvera infections, though rare, can be serious. Prompt antimicrobial treatment based on susceptibility testing leads to good outcomes, with key effective drugs including third-generation cephalosporins and fluoroquinolones.
Area of Science:
- Microbiology
- Infectious Diseases
Background:
- Kluyvera, a genus in the Enterobacteriaceae family, infrequently causes human infections.
- Its clinical significance remains debated, with varying classifications as saprophytic, opportunistic, or pathogenic.
- Recent case reports highlight diverse Kluyvera infections since the genus redefinition in 1981.
Purpose of the Study:
- To critically review all reported Kluyvera infections in the literature.
- To present an additional 5 cases from the authors' experience.
- To assess the clinical significance and treatment outcomes of Kluyvera infections.
Main Methods:
- Comprehensive literature search for Kluyvera infection case reports.
- Inclusion of 5 original patient cases.
- Analysis of clinical data, antimicrobial susceptibility, and treatment outcomes.
Main Results:
- Most patients received timely antimicrobial therapy guided by susceptibility testing.
- Favorable clinical outcomes were observed in the majority of cases.
- Effective antimicrobial agents included third-generation cephalosporins, fluoroquinolones, and aminoglycosides.
- Significant resistance was noted against ampicillin, extended-spectrum penicillins, and earlier generation cephalosporins.
Conclusions:
- Kluyvera is a potentially virulent pathogen requiring aggressive treatment.
- Treatment strategies must consider the specific antimicrobial resistance patterns of Kluyvera strains.
- Awareness of resistance profiles is crucial for effective management of Kluyvera infections.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Sexually Transmitted Infections
Urinary Tract Infection I: Introduction
Bacterial Phylum Chlamydiae
Microbiota of the Urogenital Tract

